메뉴 건너뛰기




Volumn 61, Issue 10, 2013, Pages 1121-1122

Effect of rosuvastatin on fatigue in patients with heart failure

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PLACEBO; PRAVASTATIN; ROSUVASTATIN; SIMVASTATIN;

EID: 84875454396     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2012.12.004     Document Type: Letter
Times cited : (8)

References (8)
  • 1
    • 84865440557 scopus 로고    scopus 로고
    • Effects of statins on energy and fatigue with exertion: Results from a randomized controlled trial
    • B.A. Golomb, M.A. Evans, J.E. Dimsdale, H.L. White Effects of statins on energy and fatigue with exertion: results from a randomized controlled trial Arch Intern Med 172 2012 1180 1182
    • (2012) Arch Intern Med , vol.172 , pp. 1180-1182
    • Golomb, B.A.1    Evans, M.A.2    Dimsdale, J.E.3    White, H.L.4
  • 2
    • 26644434838 scopus 로고    scopus 로고
    • A statin in the treatment of heart failure? Controlled rosuvastatin multinational study in heart failure (CORONA): Study design and baseline characteristics
    • J. Kjekshus, P. Dunselman, M. Blideskog A statin in the treatment of heart failure? Controlled rosuvastatin multinational study in heart failure (CORONA): study design and baseline characteristics Eur J Heart Fail 7 2005 1059 1069
    • (2005) Eur J Heart Fail , vol.7 , pp. 1059-1069
    • Kjekshus, J.1    Dunselman, P.2    Blideskog, M.3
  • 3
    • 36549030340 scopus 로고    scopus 로고
    • Rosuvastatin in older patients with systolic heart failure
    • J. Kjekshus, E. Apetrei, V. Barrios Rosuvastatin in older patients with systolic heart failure N Engl J Med 357 2007 2248 2261
    • (2007) N Engl J Med , vol.357 , pp. 2248-2261
    • Kjekshus, J.1    Apetrei, E.2    Barrios, V.3
  • 4
    • 77954957150 scopus 로고    scopus 로고
    • The effects of statins on skeletal muscle strength and exercise performance
    • G.M. Krishnan, P.D. Thompson The effects of statins on skeletal muscle strength and exercise performance Curr Opin Lipidol 21 2010 324 328
    • (2010) Curr Opin Lipidol , vol.21 , pp. 324-328
    • Krishnan, G.M.1    Thompson, P.D.2
  • 5
    • 0037150209 scopus 로고    scopus 로고
    • Safety and tolerability of pravastatin in long-term clinical trials: Prospective Pravastatin Pooling (PPP) Project
    • M.A. Pfeffer, A. Keech, F.M. Sacks Safety and tolerability of pravastatin in long-term clinical trials: prospective Pravastatin Pooling (PPP) Project Circulation 105 2002 2341 2346
    • (2002) Circulation , vol.105 , pp. 2341-2346
    • Pfeffer, M.A.1    Keech, A.2    Sacks, F.M.3
  • 6
    • 33845876333 scopus 로고    scopus 로고
    • Risks associated with statin therapy: A systematic overview of randomized clinical trials
    • A. Kashani, C.O. Phillips, J.M. Foody Risks associated with statin therapy: a systematic overview of randomized clinical trials Circulation 114 2006 2788 2797
    • (2006) Circulation , vol.114 , pp. 2788-2797
    • Kashani, A.1    Phillips, C.O.2    Foody, J.M.3
  • 7
    • 78449267756 scopus 로고    scopus 로고
    • Intensive lowering of LDL cholesterol with 80 mg versus 20 mg simvastatin daily in 12,064 survivors of myocardial infarction: A double-blind randomised trial
    • Study of the Effectiveness of Additional Reductions in Cholesterol and Homocysteine (SEARCH) Collaborative Group
    • Study of the Effectiveness of Additional Reductions in Cholesterol and Homocysteine (SEARCH) Collaborative Group J. Armitage, L. Bowman, K. Wallendszus et al. Intensive lowering of LDL cholesterol with 80 mg versus 20 mg simvastatin daily in 12,064 survivors of myocardial infarction: a double-blind randomised trial Lancet 376 2010 1658 1669
    • (2010) Lancet , vol.376 , pp. 1658-1669
    • Armitage, J.1    Bowman, L.2    Wallendszus, K.3
  • 8
    • 13444251203 scopus 로고    scopus 로고
    • Chemical, pharmacokinetic and pharmacodynamic properties of statins: An update
    • M. Schachter Chemical, pharmacokinetic and pharmacodynamic properties of statins: an update Fundam Clin Pharmacol 19 2005 117 125
    • (2005) Fundam Clin Pharmacol , vol.19 , pp. 117-125
    • Schachter, M.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.